Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)

About this grant

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies offering novel capabilities for targeting, probing, analyzing, handling, or performing quality control of biospecimens used for basic or clinical cancer research. This NOFO solicits R33 applications where major feasibility gaps for the technology or methodology have been ov Grant Number: RFA-CA-26-002. Expected awards: 9.

Eligibility requirements

All of the following criteria must be met:

• Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
• Grant Number: RFA-CA-26-002

What the funding covers

• Award Range: $50,000 to $3,00,000
• Expected Number of Awards: 9
• Total Program Funding: $45,00,000

How to apply

1. 1Applications must be submitted through grants.gov
2. 2Grant Number: RFA-CA-26-002
3. 3Posted: 2025-09-08

Application tips